MUMBAI, India, Oct. 12 -- Intellectual Property India has published a patent application (202617084903 A) filed by Epsilogen Ltd on July 10, 2026, for Heteromultimeric Immunoglobulin E Proteins.
Inventors include Fitzgerald, Kevin; and Macleod, Olivia.
The application for the patent was published on October 09, 2026, under issue no. 41/2026.
Abstract: Described herein are heteromultimeric proteins comprising at least two different polypeptide chains. The polypeptides may comprise Ce3 domain and/or Ce4 domain derived from an immunoglobulin E, which preferentially heterodimerize to promote formation of the heteromultimer. The two polypeptide chains may bind to two different target molecules, e.g. a cancer antigen and a T cell antigen.
Dis...